Inflammasome Therapeutics
PrivateLast Round
Seed Round
May 4, 2026
Total Funding Raised
$3.22M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Inflammasome Therapeutics is a biotechnology company that develops therapies for prevalent, degenerative diseases such as Alzheimer's, multiple sclerosis, and macular degeneration by preventing aberrant inflammasome activation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inflammasome Therapeutics Comparables
Compare Inflammasome Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NodThera | 89% | |
| Halia Therapeutics | 88% | |
| IFM Therapeutics | 87% | |
Inflammasome Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 4, 2026 | ||||
| Grant | May 1, 2025 | ||||
| Seed Round | Jan 26, 2024 | ||||
| Grant | Aug 9, 2021 | ||||
| Grant | Sep 16, 2020 | ||||
Strategic | Sep 20, 2019 |
Inflammasome Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Strategic |
| Gates Foundation | Grant |
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Grew 125% QoQ, from 4 to 9 employees.
- May 4, 2026
$13.16M raised in Seed Round.
Inflammasome Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inflammasome Therapeutics's valuation, stock price, and market status.